Role of Compositum Zeolite ® in management of inflammatory bowel disease: a pilot study.
CONCLUSIONS: Compositum Zeolite® has a compliance rate similar to the other prescribed therapies and is a good addon therapy to improve activity indexes, mainly in Crohn's disease. It also seems to improve inflammatory indexes, even if maybe dose or time of therapy were insufficient to reach a full negativization of these parameters.
PMID: 32518220 [PubMed - in process]
Source: Minerva Gastroenterologica e Dietologica - Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research
More News: Antidoxidants | Crohn's Disease | Gastroenterology | Inflammatory Bowel Disease | Nutrition | Statistics | Study | Ulcerative Colitis